A randomized controlled trial of cognitive remediation and long-acting injectable risperidone after a first episode of schizophrenia: improving cognition and work/school functioning

Nuechterlein, K. H., Ventura, J., Subotnik, K. L., Gretchen-Doorly, D., Turner, L. R., Casaus, L. R., Luo, J., Boucher, M. L., Hayata, J. N., Bell, M. D., & Medalia, A. (2020). A randomized controlled trial of cognitive remediation and long-acting injectable risperidone after a first episode of schizophrenia: improving cognition and work/school functioning. Psychological Medicine, 52(8), 1517–1526. https://doi.org/10.1017/s0033291720003335
Authors:
Keith H. Nuechterlein
Joseph Ventura
Kenneth L. Subotnik
Denise Gretchen-Doorly
Luana R. Turner
Laurie R. Casaus
John Luo
Michael L. Boucher
Jacqueline N. Hayata
Morris D. Bell
Alice Medalia
Affiliated Authors:
Alice Medalia
Author Keywords:
cognitive training
functional outcome
long-acting injectable antipsychotic
Publication Type:
Article
Unique ID:
10.1017/S0033291720003335
PMID:
Publication Date:
Data Source:
Scopus

Record Created: